TransMedics Group, Inc. TMDX
67.34 USD +0.67 (+1.00%)
Nov 3, 2026, 3:24 PM EST
66.36 Day range 68.82
60.11 52-week range 156.00
- YTD
- -44.65%
- 1 year
- -46.01%
Analyst view
Consensus: buy
Buy
Price target (mean) 98.73 +46.6% upside
Now 67.34
- Target (low)
- 65.00
- Target (mean)
- 98.73
- Target (high)
- 125.00
Ratings (0m) 13 9 buy · 4 hold · 0 sell
- Strong buy3
- Buy6
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.2934 | 0.14738 – 0.40167 | 0.66 | -55.5% | 178.05M | +23.8% | 10 |
| Next quarter | 0.49927 | 0.30964 – 0.57 | 0.527 | -5.3% | 201.27M | +25.2% | 9 |
| Current year | 1.51 | 1.17 – 1.63 | 2.63 | -42.4% | 742.18M | +22.6% | 10 |
| Next year | 2.25 | 1.61 – 3.04 | 1.51 | +49.0% | 874.68M | +17.8% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Overweight |
| Sep 8, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Aug 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Aug 3, 2026 | Needham | Maintained | Buy | Buy |
| Jul 28, 2026 | UBS | Initiated | — | Neutral |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 1, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Jun 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 18, 2026 | Stifel | Maintained | Hold | Hold |
| May 26, 2026 | Stifel | Maintained | Hold | Hold |
| May 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 6, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 6, 2026 | Stifel | Maintained | Hold | Hold |
| May 6, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| May 6, 2026 | Needham | Maintained | Buy | Buy |
| Apr 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Mar 9, 2026 | Stifel | Maintained | Hold | Hold |
| Feb 25, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 25, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 25, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Feb 25, 2026 | Needham | Maintained | Buy | Buy |
| Dec 17, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 8, 2025 | Needham | Maintained | Buy | Buy |
| Dec 2, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 30, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 23, 2025 | Needham | Upgrade | Hold | Buy |